Literature DB >> 15793800

Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics.

Zimei Wu1, Majid Razzak, Ian G Tucker, Natalie J Medlicott.   

Abstract

The physicochemical properties of ricobendazole (RBZ) were characterized using conventional methods. Solubility in some pharmaceutical solvents, pH-solubility, ionization properties, and lipophilicity are described. The solubility of RBZ in water is 62 mug/mL and very poor in common pharmaceutical solvents, for example, oils (<0.25 mg/mL in all the tested oils) or ethanol (1.2 mg/mL) and propylene glycol (2.6 mg/mL), and slightly higher in dipolar solvents, DMSO (16.5 mg/mL). U-shaped pH-solubility profile in aqueous solutions indicates RBZ is an ampholyte. pK(a) values measured by absorbance spectroscopy and pH solubility methods were 3.45 and 3.76 for the basic group and 9.82 and 9.53 for the non-basic nitrogen, respectively. Combination of low pH and surfactant/co-solvent mixtures also improved solubility. RBZ formed a 1:1 complex with hydroxypropyl-beta-cyclodextrin (HP-beta-CD) with a binding constant (K(1:1)) of 311/M1. Apparent partition coefficients of RBZ were 14.3-15.2 at pH 6-9 and reduced at higher or lower pH. In conclusion, traditional organic co-solvents, pH-adjustment or complexation (with HP-beta-CD) approaches are unlikely to yield sufficient solubility for formulation of RBZ solutions for subcutaneous injection and novel approaches should be considered. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793800     DOI: 10.1002/jps.20282

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Investigation into the Emerging Role of the Basic Amino Acid L-Lysine in Enhancing Solubility and Permeability of BCS Class II and BCS Class IV Drugs.

Authors:  Hamdy Abdelkader; Zeinab Fathalla
Journal:  Pharm Res       Date:  2018-06-18       Impact factor: 4.200

2.  Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.

Authors:  Laura Ceballos; Laura Moreno; Juan J Torrado; Carlos Lanusse; Luis Alvarez
Journal:  BMC Vet Res       Date:  2012-05-28       Impact factor: 2.741

3.  Development of a novel approach to enhance the solubility of ftibamzone formulation.

Authors:  Ofonime Udofot; Kristen Jaruszewski; Shawn Spencer; Edward Agyare
Journal:  Integr Mol Med       Date:  2014

4.  Exploring the Preparation of Albendazole-Loaded Chitosan-Tripolyphosphate Nanoparticles.

Authors:  Bong-Seok Kang; Sang-Eun Lee; Choon Lian Ng; Jin-Ki Kim; Jeong-Sook Park
Journal:  Materials (Basel)       Date:  2015-02-05       Impact factor: 3.623

5.  Floating Ricobendazole Delivery Systems: A 3D Printing Method by Co-Extrusion of Sodium Alginate and Calcium Chloride.

Authors:  Giovanni Falcone; Juan P Real; Santiago D Palma; Rita P Aquino; Pasquale Del Gaudio; Emilia Garofalo; Paola Russo
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

6.  Study on biopharmaceutics classification and oral bioavailability of a novel multikinase inhibitor NCE for cancer therapy.

Authors:  Yang Yang; Chun-Mei Fan; Xuan He; Ke Ren; Jin-Kun Zhang; Ying-Ju He; Luo-Ting Yu; Ying-Lan Zhao; Chang-Yang Gong; Yu Zheng; Xiang-Rong Song; Jun Zeng
Journal:  Int J Mol Sci       Date:  2014-04-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.